Furthermore, current research on vaccines targeting V. fluvialis OMPs remains limited, particularly regarding the development of multivalent OMP vaccines against multiple bacterial infections; therefore, further investigations are warranted to create multivalent vaccines against bacterial infection. This evidence concerns the gene OMP and bacterial infectious disease.